Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with Stage I non-small-cell lung cancer?

Interactive Cardiovascular and Thoracic Surgery

Volumn 17, Issue 5, 2013, Pages 845-853

  Mahmood, Sarah ^a   Bilal, Haris ^b   Faivre Finn, Corinne ^c   Shah, Rajesh ^b  

^a ROYAL OLDHAM HOSPITAL   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Non Small cell lung cancer; Stereotactic ablative radiotherapy; Sublobar resection; Survival

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; DISEASE FREE SURVIVAL; EARLY CANCER; EVIDENCE BASED PRACTICE; FATIGUE; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; LOBECTOMY; LUNG RESECTION; MORBIDITY; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION PNEUMONIA; STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC TREATMENT; SUBLOBAR RESECTION; SURGICAL PATIENT; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; THORAX PAIN; TUMOR VOLUME; EVIDENCE BASED MEDICINE; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MORTALITY; NON-SMALL-CELL LUNG CANCER; PATHOLOGY; PATIENT SELECTION; QUALITY CONTROL; RADIOSURGERY; REVIEW; RISK FACTOR; SURVIVAL; TIME; TREATMENT OUTCOME;

NON-SMALL-CELL LUNG CANCER; STEREOTACTIC ABLATIVE RADIOTHERAPY; SUBLOBAR RESECTION; SURVIVAL;

BENCHMARKING; CARCINOMA, NON-SMALL-CELL LUNG; EVIDENCE-BASED MEDICINE; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PATIENT SELECTION; PNEUMONECTOMY; RADIOSURGERY; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84902404159     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivt262     Document Type: Article

References (22)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: Best BETS. Interact CardioVasc Thorac Surg 2003;2:405-9.
2. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-23.
3. Fernando HC, Landreneau RJ, Mandrekar SJ, Hillman SL, Nichols FC, Meyers B et al. Thirty- And ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: Results from a multicenter phase III study. J Thorac Cardiovasc Surg 2011;142:1143-51.
4. Fan J, Wang L, Jiang GN, Gao W. Sublobectomy versus lobectomy for stage I non-small-cell lung cancer, a meta-analysis of published studies. Ann Surg Oncol 2012;19:661-8.
5. Birdas TJ, Koehler RP, Colonias A, Trombetta M, Maley RH Jr, Landreneau RJ et al. Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer. Ann Thorac Surg 2006;81:434-9.
6. Fernando HC, Santos RS, Benfield JR, Grannis FW, Keenan RJ, Luketich JD et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2005;129:261-7.
7. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A et al. Effect of tumor size on prognosis in patients with non-small cell lung cancer: The role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg 2005;129:87-93.
8. Keenan RJ, Landreneau RJ, Maley RH Jr, Singh D, Macherey R, Bartley S et al. Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg 2004;78:228-33.
9. Koike T, Yamato Y, Yoshiya K, Shimoyama T, Suzuki R. Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg 2003;125:924-8.
10. Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg 2010;211:68-72.
11. Haasbeek CJ, Lagerwaard FJ, Antonisse ME, Slotman BJ, Senan S. Stage I non small cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapy. Cancer 2010;116:406-14.
12. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303:1070-6.
13. Ricardi U, Filippi AR, Guarneri A, Giglioli FR, Ciammella P, Franco P et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial. Lung Cancer 2010;68: 72-7.
14. Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA et al. Stereotactic body radiation therapy for early-stage non-smallcell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009;75:677-82.
15. Lagerwaard FJ, Haasbeek CJ, Smit EF, Slotman BJ, Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2008;70:685-92.
16. Le QT, Loo BW, Ho A, Cotrutz C, Koong AC, Wakelee H et al. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol 2006;1:802-9.
17. Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K et al. Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004;101:1623-31.
18. Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006;24:4833-9.
19. Haasbeek CJ, Lagerwaard FJ, Slotman BJ, Senan S. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. J Thorac Oncol 2011;6:2036-43.
20. Puri V, Crabtree T, Kymes S, Gregory M, Bell J, Bradley J et al. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: A decision analysis. J Thorac Cardiovasc Surg 2012;143:428-36.
21. Grills IS, Mangona VS, Welsh R, Chmielewski G, McInerney E, Martin S et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 2010;28:928-35.
22. Forquer JA, McGarry RC, Kesler KA, Juliar BE, Watson C, Harkenrider M et al. A Matched-Pair Analysis of Sublobar Resection and Stereotactic Body Radiotherapy (SBRT) for Stage I NSCLC. Int J Radiat Oncol Biol Phys 2007;69:S492-3.